MTOR and neoplasm: Our study found that NEDD4 mediated the ubiquitination and degradation of PTEN by binding to PTEN, which activated the downstream PI3K/Akt/mTOR signaling pathway, thus promoting OXA and 5-Fu resistance in tumor cells.